GSK plc - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 12, 2026, for the 2025 Q4 period, GSK plc held in its portfolio 15 assets valued at $799,022,938 (i.e. $799.02M).

The most valuable assets in the portfolio included: WAVE LIFE SCIENCES LTD ($310.18M), CRISPR THERAPEUTICS AG ($168.89M), and BIONTECH SE ($84.71M).

The chart below shows the top 10 valuable assets, and the table below shows the top 15 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in GSK plc Portfolio

WAVE LIFE SCIENCES LTD

CRISPR THERAPEUTICS AG

BIONTECH SE

VIR BIOTECHNOLOGY INC

LYELL IMMUNOPHARMA INC

IDEAYA BIOSCIENCES INC

CYTOKINETICS INC

SPERO THERAPEUTICS INC

FULCRUM THERAPEUTICS INC

BICYCLE THERAPEUTICS PLC

GSK plc - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
WAVE LIFE SCIENCES LTD	18245691	310176747	SHS
CRISPR THERAPEUTICS AG	3220627	168889680	NAMEN AKT
BIONTECH SE	889824	84711245	SPONSORED ADS
VIR BIOTECHNOLOGY INC	8550954	51562253	COM
LYELL IMMUNOPHARMA INC	1512659	46559644	COM NEW
IDEAYA BIOSCIENCES INC	1333333	46093322	COM
CYTOKINETICS INC	340434	21631176	COM NEW
SPERO THERAPEUTICS INC	9190606	21414112	COM
FULCRUM THERAPEUTICS INC	1785714	20196425	COM
BICYCLE THERAPEUTICS PLC	1529561	10829292	SPONSORED ADS
CVRX INC	1007583	7153839	COM
NKARTA INC	3150732	5828854	COM
REGENXBIO INC	271456	3908966	COM
SENSEONICS HLDGS INC	10856	59925	COM
HARVARD BIOSCIENCE INC	11151	7458	COM